NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Friday, March 7, 2014
The University of Cincinnati's Division of Transplantation The Division of Transplantation provides kidney, pancreas and liver transplantation. The Division is a leader in laparoscopic nephrectomy, immunosuppressive drug development, corticosteroid elimination, laparoscopic liver surgery, dialysis access research, and the development of paired kidney donation programs. Robotic-assisted surgery and islet cell transplantation offer new hope for high-risk patients.
The UC Liver Transplant Program is the busiest program in Ohio, with an average of 50 liver transplants per year. The Division has performed over 500 laparoscopic donor nephrectomies and is one of a very small number of programs that performs 100% of living-donor nephrectomies laparoscopically.
Simultaneous kidney-pancreas, pancreas after kidney, and solitary pancreas transplants are performed by Division faculty. The Paired Donation Network continues to grow, increasing access for patients to paired kidney donation programs across the United States.
The Division has excelled in the area of hepatobiliary surgery for benign and malignant tumors of the pancreas, liver and biliary tree, having performed over 1,000 advanced hepatobiliary surgical procedures. The Division has one of the world’s largest experiences in laparoscopic liver resections and hosts two training courses annually.
The Division offers a certified transplant fellowship training program and a fellowship in transplant pharmacology.
The Division has developed a world-class immunosuppressive drug development program as well as clinical trials in the kidney, islet cell, and pancreas transplant programs. Funded studies include several large, multicenter trials with UC as the flagship center.
This article is a NetWellness exclusive.
Last Reviewed: Feb 25, 2014